These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26165387)

  • 1. Why are there no FDA-approved treatments for female sexual dysfunction?
    Nappi RE
    Expert Opin Pharmacother; 2015; 16(12):1735-8. PubMed ID: 26165387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
    Kingsberg SA; Althof SE
    J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I; Simon JA
    Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in pharmacotherapy for treating female sexual dysfunction.
    Nappi RE; Cucinella L
    Expert Opin Pharmacother; 2015 Apr; 16(6):875-87. PubMed ID: 25732267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Davis SR; Braunstein GD
    J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs in early clinical development for the treatment of female sexual dysfunction.
    Belkin ZR; Krapf JM; Goldstein AT
    Expert Opin Investig Drugs; 2015 Feb; 24(2):159-67. PubMed ID: 25376023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
    Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
    Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert opinion on existing and developing drugs to treat female sexual dysfunction.
    Miller MK; Smith JR; Norman JJ; Clayton AH
    Expert Opin Emerg Drugs; 2018 Sep; 23(3):223-230. PubMed ID: 30251897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

  • 14. Flibanserin and Female Sexual Desire.
    Fantasia HC
    Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Female sexual dysfunction: Drug treatment options].
    Alcántara Montero A; Sánchez Carnerero CI
    Semergen; 2016; 42(5):e33-7. PubMed ID: 27041639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen treatment of postmenopausal women.
    Davis SR; Worsley R
    J Steroid Biochem Mol Biol; 2014 Jul; 142():107-14. PubMed ID: 23727129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flibanserin and its discontents.
    Aftab A; Chen C; McBride J
    Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.